Equities
  • Price (EUR)0.50
  • Today's Change0.00 / 0.00%
  • Shares traded3.60k
  • 1 Year change-49.24%
  • Beta--
Data delayed at least 15 minutes, as of Jun 21 2024 14:29 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Renergen Limited is a South Africa-based investment holding company focused on investing in prospective green projects. The Company is a liquid helium and liquefied natural gas (LNG) producer. It is focused on delivering helium and domestic natural gas in South Africa and Sub-Saharan Africa. The Company's segments include Tetra4, Cryovation and Corporate head office. Tetra4 segment explores for, develops and sells compressed natural gas (CNG) to the South African market. Cryovation segment consists of Cryo-Vacc technology, which enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power. The Company’s projects include Virginia Gas project (Tetra4). Its Tetra4 project comprises exploration and production rights of approximately 187 000 hectares (ha) of CNG fields across Welkom, Virginia and Theunissen, in the Free State Province and Mpumalanga Province in the town of Evander.

  • Revenue in ZAR (TTM)28.95m
  • Net income in ZAR-110.27m
  • Incorporated2014
  • Employees69.00
  • Location
    RENERGEN Ltd1 Bompas Road, Dunkeld WestDUNKELD 2196South AfricaZAF
  • Phone+27 100456000
  • Websitehttps://renergen.co.za/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.